Dossier
Yamanaka Factors
Coverage of Yamanaka Factors in the Nexus archive.
- The first-ever reverse-aging drug was just injected into a human
A reverse-aging drug was injected into a human for the first time by Boston-based biotech startup Life Biosciences. The treatment targets age-related diseases through cellular reprogramming, with initial testing on a patient with glaucoma. Billionaires and pharmaceutical companies, including Jeff Bezos, Sam Altman, Eli Lilly, and Merck, are investing in this longevity science.